September 2021 - Patrick Anquetil sat down with ASAP Biopharma ahead of his keynote "Alliance Managers Are Bringing Digital Health Innovation" which is slated for 10:20 a.m. EDT on September 28th. The keynote will be followed by a Q&A session.
Patrick Anquetil, PhD, MBA sat down with ASAP Biopharma ahead of his keynote “Alliance Managers Are Bringing Digital Health Innovation” which is slated for 10:20 a.m. EDT on September 28th. Dr. Anquetil will reveal how Portal’s alliance governance, framework, and execution are inextricably linked to the advancement of this groundbreaking drug-delivery mechanism. After the keynote Dr. Anquetil plans to have a Q&A session and discussion of any aspect of innovation that isn’t covered in his presentation, including but not limited to issues related to regulatory, manufacturing, and commercial phases of the drug development life cycle.
Read the full interview here: ASAP BioPharma Conference Keynote Preview: Alliance Managers Are Bringing Digital Health Innovation
Steven Kaufman talks with ONdrugDelivery about the world of autoinjectors, looking at the current status quo in the industry, using Portal Instruments’ PRIME Nexus™ smart reusable electromechanical autoinjector as a lens to bring into focus how things have changed and where they might be going.
June 30, 2021 - The National Transgender Discrimination Survey Report on Health and Health Care recorded at least 80% of transgender people have either taken gender-affirming hormone therapy (GAHT) or want to take GAHT at some point.¹
Portal Instruments is pleased to be showcasing its latest drug delivery platform at the LSI conference in California next week. CEO Patrick Anquetil will be available for personalized demonstrations and in-depth discussions about the technology's benefits and potential impact.
Please fill out the details below and we will get back to you shortly.